Table 4.

Adjusted Odds Ratios of Outcomes 6 to 12 Months After Index DKA Episode Three Categories of A− β+ KPD Patients^a,c

A− β+ KPD Patient Groups	Odds Ratiob	95% Confidence Interval	P value
Unprovoked-AP
Age (years)	0.97	[0.94, 1.01]	.29
BMI (kg/m2)	1.01	[0.96, 1.07]	.57
Duration of diabetes (years)	0.31	[0.17, 0.58]	<.001
HbA1c (%)	.906	[0.71, 1.15]	.43
Fasting C-peptide (ng/mL)	.854	[0.59, 1.23]	.40
GST-AUC C-peptide (ng/mL over 10 min)	1.04	[1.02, 1.07]	.04
Provoked-AP
Age (years)	.984	[0.93, 1.03]	.50
BMI (kg/m2)	1.01	[0.94, 1.08]	.83
Duration of diabetes (years)	0.63	[0.46, 0.85]	.003
HbA1c (%)	1.36	[1.04, 1.76]	.02
Fasting C-peptide (ng/mL)	1.22	[0.79, 1.88]	.37
GST-AUC C-peptide (ng/mL over 10 min)	1.01	[0.98, 1.05]	.41

Abbreviations: AP = acute pancreatitis; BMI = body mass index; GST-AUC C-peptide = area-under-the-curve (AUC) for C-peptide during a glucagon stimulation test (GST); HbA1c = hemoglobin A1c; KPD = ketosis-prone diabetes.

^aThe reference category is the Provoked-Other A−β+ KPD group.

^bOdds ratios were calculated from multinomial logistic regression analysis.

^cA lack of significance (and odds ratio values) showed that participants were similar with respect to age, BMI, and fasting C-peptide level.